UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 198

Sortiert nach

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

Nature communications, 2018-02, Vol.9 (1), p.741-14, Article 741

2018

Link zum Volltext

Verfügbarkeit prüfen

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

Proceedings of the National Academy of Sciences - PNAS, 2011-10, Vol.108 (41), p.17111-17116

2011

Link zum Volltext

Verfügbarkeit prüfen

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

The Journal of experimental medicine, 2006-11, Vol.203 (12), p.2691-2702

2006

Link zum Volltext

Verfügbarkeit prüfen

A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

Blood, 2010-11, Vol.116 (18), p.3554-3563

2010

Link zum Volltext

Verfügbarkeit prüfen

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

Cancer research (Chicago, Ill.), 2004-09, Vol.64 (17), p.6337-6343

2004

Link zum Volltext

Verfügbarkeit prüfen

Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

Cancer research (Chicago, Ill.), 2008, Vol.68 (1), p.190-197

2008

Link zum Volltext

Verfügbarkeit prüfen

Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma

Science translational medicine, 2015-05, Vol.7 (288), p.288ra78

2015

Link zum Volltext

Verfügbarkeit prüfen

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Blood, 2010-04, Vol.115 (16), p.3224-3230

2010

Link zum Volltext

Verfügbarkeit prüfen

Embracing Myeloma Chimeric Antigen Receptor-T: From Scientific Design to Clinical Impact

American Society of Clinical Oncology educational book, 2023-06, Vol.43 (43), p.e389860-e389860

2023

Link zum Volltext

Verfügbarkeit prüfen

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

Journal of translational medicine, 2017-07, Vol.15 (1), p.155-155, Article 155

2017

Link zum Volltext

Verfügbarkeit prüfen

Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells

Blood, 2014-01, Vol.123 (5), p.725-733

2014

Link zum Volltext

Verfügbarkeit prüfen

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma

Journal for immunotherapy of cancer, 2020-07, Vol.8 (2), p.e000734

2020

Link zum Volltext

Verfügbarkeit prüfen

Marrow Infiltrating Lymphocytes: Their Role in Adoptive Immunotherapy

The cancer journal (Sudbury, Mass.), 2015-11, Vol.21 (6), p.501

2015

Link zum Volltext

Verfügbarkeit prüfen

Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort

International journal of cardiology, 2021-03, Vol.326, p.131-138

2021

Link zum Volltext

Verfügbarkeit prüfen

The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies

Blood, 2016-09, Vol.128 (13), p.1679-1687

2016

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy

Journal of the peripheral nervous system, 2008-12, Vol.13 (4), p.275-282

2008

Link zum Volltext

Verfügbarkeit prüfen

Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patients

Leukemia & lymphoma, 2018-12, Vol.59 (12), p.2801-2811

2018

Link zum Volltext

Verfügbarkeit prüfen

Can we change the disease biology of multiple myeloma?

Leukemia research, 2012-11, Vol.36 (1), p.S3-S12

Borrello, Ivan

2012

Link zum Volltext

Verfügbarkeit prüfen

Granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)

Blood, 2009-08, Vol.114 (9), p.1736-1745

2009

Link zum Volltext

Verfügbarkeit prüfen

Flow cytometric discrimination of seven lineage markers by using two fluorochromes

PloS one, 2017-11, Vol.12 (11), p.e0188916-e0188916

2017

Link zum Volltext

Verfügbarkeit prüfen

Marrow Infiltrating Lymphocytes and Vaccines in Myeloma

Blood, 2016-12, Vol.128 (22), p.SCI-35-SCI-35

Borrello, Ivan

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Englisch
(198)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Embracing Myeloma Chimeric Antigen Receptor-T: From Scientific Design to Clinical Impact

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial

Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma

Marrow Infiltrating Lymphocytes: Their Role in Adoptive Immunotherapy

Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort

The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies

Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy

Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study

Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patients

Can we change the disease biology of multiple myeloma?

Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study

Granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)

Flow cytometric discrimination of seven lineage markers by using two fluorochromes

Marrow Infiltrating Lymphocytes and Vaccines in Myeloma

Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide

Suchergebnisse filtern